ResearcherYokohama Rosai HospitalActive in the last 2 years

Noriki Kasuga

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3154-5535; OpenAlex author ID A5009412654. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2023: 2 papers · 2024: none · 2025: none · 2026: 1 paper

Papers 3

A Case of Recurrent Acute Pancreatitis After Gemcitabine + Nab-Paclitaxel and Modified FOLFIRINOX Therapy for Advanced Recurrent Pancreatic Cancer. Co-author DOI 10.7759/cureus.102865 ↗
Maintaining early diagnosis of pancreatic adenocarcinoma in Japan: Local resilience against COVID-19. Co-author DOI 10.1016/j.pan.2023.06.002 ↗
Clinical Features and Prognostic Impact of Pancreatic Ductal Adenocarcinoma without Dilatation of the Main Pancreatic Duct: A Single-Center Retrospective Analy… Co-author DOI 10.3390/diagnostics13050963 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Takuya Takayanagi · 2 shared papers, 2023 · strength 0.42
- Paper Clinical Features and Prognostic Impact of Pancreatic Ductal Adenocarcinoma without Dilatation of the Main Pancreatic D… DOI 10.3390/diagnostics13050963 ↗
- Paper Maintaining early diagnosis of pancreatic adenocarcinoma in Japan: Local resilience against COVID-19. DOI 10.1016/j.pan.2023.06.002 ↗
Atsushi Nakajima · 2 shared papers, 2023 · strength 0.42
- Paper Clinical Features and Prognostic Impact of Pancreatic Ductal Adenocarcinoma without Dilatation of the Main Pancreatic D… DOI 10.3390/diagnostics13050963 ↗
- Paper Maintaining early diagnosis of pancreatic adenocarcinoma in Japan: Local resilience against COVID-19. DOI 10.1016/j.pan.2023.06.002 ↗
Yusuke Inada · 1 shared paper, 2026 · strength 0.39
- Paper A Case of Recurrent Acute Pancreatitis After Gemcitabine + Nab-Paclitaxel and Modified FOLFIRINOX Therapy for Advanced … DOI 10.7759/cureus.102865 ↗
Motohiko Sano · 1 shared paper, 2026 · strength 0.39
- Paper A Case of Recurrent Acute Pancreatitis After Gemcitabine + Nab-Paclitaxel and Modified FOLFIRINOX Therapy for Advanced … DOI 10.7759/cureus.102865 ↗
Yusuke Kurita · 1 shared paper, 2023 · strength 0.20
- Paper Maintaining early diagnosis of pancreatic adenocarcinoma in Japan: Local resilience against COVID-19. DOI 10.1016/j.pan.2023.06.002 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.